SCHEMBL7325004

SCHEMBL7325004

COC(=O)C1=C(C)NC(CO)=C(C(=O)OC(C)C)C1c1cccc(Cl)c1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.64
CYP3A4 P08684 5/20 0.64
TBXA2R P21731 5/20 0.64
CYP1A2 P05177 4/20 0.64
CYP2C19 P33261 4/20 0.64
ABCB11 O95342 4/20 0.64
SLC6A3 Q01959 4/20 0.64
ADORA3 P0DMS8 4/20 0.64
SCN5A Q14524 4/20 0.64
NR1I2 O75469 4/20 0.64
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
KDM4E B2RXH2 3/20 0.64
OPRK1 P41145 3/20 0.64
ADRA1A P35348 3/20 0.64
NPSR1 Q6W5P4 3/20 0.64
NR3C1 P04150 3/20 0.64
PDE4D Q08499 3/20 0.64
ABCB1 P08183 3/20 0.64
HIF1A Q16665 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10933416 0.93 CYP2C9 (0.73) CYP2C9CYP3A4TBXA2RCYP1A2CYP2C19
SCHEMBL7429254 0.92 CYP2C9 (0.64) CYP2C9CYP3A4TBXA2RCYP1A2CYP2C19
SCHEMBL7408943 0.90 CYP2C9 (0.73) CYP2C9CYP3A4TBXA2RCYP1A2CYP2C19
SCHEMBL9770423 0.88 CYP2C9 (0.62) CYP2C9CYP3A4TBXA2RCYP1A2CYP2C19
Lemildipine SCHEMBL49443 0.88 CYP2C9 (0.62) CYP2C9CYP3A4TBXA2RCYP1A2CYP2C19
Lemildipine SCHEMBL29801339 0.88 CYP2C9 (0.62) CYP2C9CYP3A4TBXA2RCYP1A2CYP2C19
Lemildipine SCHEMBL49442 0.88 CYP2C9 (0.62) CYP2C9CYP3A4TBXA2RCYP1A2CYP2C19
SCHEMBL10370006 0.88 CYP2C9 (0.83) CYP2C9CYP3A4TBXA2RCYP1A2CYP2C19
SCHEMBL14506218 0.88 CYP2C9 (0.58) CYP2C9CYP3A4TBXA2RCYP1A2CYP2C19
SCHEMBL10933425 0.87 CYP2C9 (0.65) CYP2C9CYP3A4TBXA2RCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0311053-A2 Ameliorant of cerebral circulation and optical isomer of nb-818, processes for its production and its use BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-04-12 EP claimed
US-5494923-A Method of ameliorating cerebral circulation BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-02-27 US disclosed
US-5444077-A Ameliorant of cerebral circulation and optical isomer of NB-818, processes for its use BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-22 US disclosed
EP-0311053-A2 Ameliorant of cerebral circulation and optical isomer of nb-818, processes for its production and its use BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-04-12 EP disclosed